Tissue Engineered Veins in Patients With Chronic Venous Insufficiency

计划入组 11 人 · 首次发布于 2018 年 12 月 21 日

Mass Balance Clinical Trial With TEV-56286

计划入组 8 人 · 首次发布于 2024 年 10 月 4 日

A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo

计划入组 66 人 · 首次发布于 2024 年 10 月 3 日

TEV-289

TEV-408

TEV -295

DR APOORVA A P

India

DENVER NEPHROLOGISTS P C

United States

Hugh P McElwee Md

United States

VERIGRAFT Initiates Pivotal Phase II/III Trial for First Potential Curative CVI Treatment

Fremanezumab Shows Positive Phase 3 Results for Episodic Migraine Prevention in Children and Adolescents

Teva's TEV-'749 Shows Promise in Improving Social Functioning in Schizophrenia Patients